NUWE
Nuwellis, Inc.Company Information
- Company Name
- Nuwellis, Inc.
- CIK
- CIK0001506492
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NUWE: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- NUWE
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-03-15
- Last sale
- —
- Shares purchased (TTM)
- 4,098
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 20,964
- Shares outstanding
- 181,243
- Ownership
- 11.57%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -40.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 2 | 1 | 3 | 4 | 3 | 5 | 2 | 1 | 1 | 4 | 5 | ||||||
| Accounts Receivable Net Current | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Inventory Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Assets Current | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | ||||||
| Assets Current | 8 | 6 | 5 | 7 | 8 | 6 | 9 | 5 | 5 | 5 | 8 | 10 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 9 | 7 | 6 | 8 | 9 | 7 | 10 | 7 | 6 | 7 | 10 | 11 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 3 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 2 | 2 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Employee Related Liabilities Current | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 4 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | ||||||
| Finance Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities | 11 | 4 | 3 | 4 | 18 | 3 | 3 | 4 | 13 | 6 | 7 | 4 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 324 | 324 | 319 | 318 | 305 | 305 | 305 | 301 | 293 | 293 | 291 | 290 | ||||||
Accumulated Other Comprehensive Income Loss Net Of Tax | ||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -326 | -321 | -316 | -314 | -314 | -302 | -299 | -297 | -300 | -292 | -288 | -282 | ||||||
| Stockholders Equity | -2 | 3 | 3 | 4 | -9 | 4 | 7 | 3 | -7 | 1 | 3 | 8 | ||||||
| Liabilities And Stockholders Equity | 9 | 7 | 6 | 8 | 9 | 7 | 10 | 7 | 6 | 7 | 10 | 11 | ||||||
| Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | 39 | - | - | - | 39 | 39 | 39 | 39 | 39 | 40 | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | 39 | 39 | - | 39 | 39 | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 1 | 3 | 2 | 1 | 1 | 4 | 0 | 2 | 1 | 7 | 0 | 2 | ||||||
| Shares Outstanding | 1 | 3 | 2 | 1 | 1 | 4 | 0 | 2 | 1 | 7 | 0 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNuwellis, Inc. (NUWE) — SEC Financial Statements & Analysis
Nuwellis, Inc. (NUWE) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Nuwellis, Inc. trades on Nasdaq as: NUWE. Nuwellis, Inc. (NUWE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Nuwellis, Inc. carries a market cap of $552.79K, a P/E ratio of -0.05x, a P/B ratio of -0.27x, a P/S ratio of 0.06x, an enterprise value of $-3.48M, and an EV/EBITDA multiple of 0.27x. On profitability, it posts a gross margin of 69.69%, an operating margin of -142.87%, a net margin of -125.57%, a Return on Equity (ROE) of 205.50%, a Return on Assets (ROA) of -123.52%, and a Return on Invested Capital (ROIC) of -1367.74%. Per share, it reports EPS of $-62.45, diluted EPS of $-62.45, free cash flow per share of $-69.59, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 8.36% year-over-year, net income growth of -22.88% year-over-year, and EPS growth of -97.50% year-over-year. On the balance sheet, it maintains a current ratio of 1.97x, a quick ratio of 1.54x, working capital of $3.89M, a debt-to-equity ratio of -5.44x, a debt ratio of 1.22, free cash flow of $-12.61M (TTM), and net debt of $-4.03M. Figures sourced from SEC EDGAR.
- Market Cap
- $552.79K
- P/E TTM
- -0.05x
- EPS TTM
- $-62.45
- P/B TTM
- -0.27x
- ROE TTM
- 205.50%
- ROA TTM
- -123.52%
- Debt To Equity
- -5.44x
- Free Cash Flow TTM
- $-12.61M
- Net Revenue TTM Growth 1Y
- 8.36%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Nuwellis, Inc. in?
Nuwellis, Inc. (NUWE) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does NUWE trade on?
Nuwellis, Inc. (NUWE) trades on the Nasdaq.
Where is Nuwellis, Inc. incorporated?
Nuwellis, Inc. is incorporated in DE.
When was Nuwellis, Inc. (NUWE)'s most recent SEC filing?
Nuwellis, Inc. (NUWE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is NUWE's market cap?
Nuwellis, Inc. (NUWE) has a market capitalization of $552.79K as of 2026-06-30.
What is NUWE's EPS (earnings per share)?
Nuwellis, Inc. (NUWE)'s trailing twelve month EPS is $-62.45 as of 2026-06-30.
What is NUWE's ROE (return on equity)?
Nuwellis, Inc. (NUWE)'s trailing twelve month Return on Equity (ROE) is 205.50% as of 2026-06-30.
What is NUWE's ROA (return on assets)?
Nuwellis, Inc. (NUWE)'s trailing twelve month Return on Assets (ROA) is -123.52% as of 2026-06-30.
What is NUWE's ROIC (return on invested capital)?
Nuwellis, Inc. (NUWE)'s trailing twelve month Return on Invested Capital (ROIC) is -1367.74% as of 2026-03-31.
What is NUWE's EV/EBITDA?
Nuwellis, Inc. (NUWE)'s trailing twelve month EV/EBITDA is 0.27x as of 2026-06-30.